🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New data from The ELAN Trial presented by Stroke Research Center Bern Urs Martin Fischer and Martina Göldlin suggest that benefit of early start of DOAC after stroke is equal for all stroke sizes, probably even biggest in large sized strokes. Investigators did a great job estimimating stroke size 👏👏

Fellowship Training Directors: #ACGME's Revised NCC Program Requirements are releasing this week and expect to address the lack of availability of qualified RFP neurosurgeons to serve as core faculty in NCC fellowship programs. Review, comment and share: ow.ly/3f6h50QBv8J

You can now read our latest paper JAMA Network Open The evidence from RCTs suggests that intensive post-EVT BP reduction does not yield benefits and may carry risks. Read more here: bit.ly/49K1RjL Mohamed Elfil, MD Hassan Kobeissi, M.D. Alzhraa Abbas, MD MayoNeurovascularLab

The Jefferson Telestroke Program being presented by Omar Shah MD MBA Jefferson Neurosurgery Jefferson Health Neuroscience Jefferson Neurology

Congratulations to Dr. Michael Sperling, the proud recipient of the American Clinical Neurophysiology Society, Herbert H. Jasper Award, recognizing a lifetime of outstanding contributions to the field of clinical neurophysiology including research, teaching, and mentoring.

Our latest in JAMA Neurology. A systematic review of 66 studies (1637 patients) for RSE with CI ASMs. Lots of interesting findings including epilepsy related RSE with lower mortality compared to other etiologies. Jefferson Neurocritical Care Andres Fernandez L J Hirsch tinyurl.com/kvh7ark5

How should #neurocriticalcare divisions build onboarding programs for new advanced practice providers? And what activities should NCC #APPs be expected to perform by the end of onboarding? We addressed these ❓❓ in our manuscript in Critical Care Medicine! A 🧵 journals.lww.com/ccmjournal/abs…

#MondayTip 🩸ICH Dawn of a New Era 🌎"ICH is a devastating disease, causing high rates of death, disability, and suffering across the world" 🎉2023 was a good year in ICH field: INTERACT3 ENRICH ANNEXa-1 💪and 2024 is not disappointing: INTERACT4 SWITCH 🔗journals.sagepub.com/doi/10.1177/17…

It’s that time of the year! Celebrating the graduation of our amazing stroke fellows, Mitchell & Courtney! Jefferson Health Neuroscience Jefferson GME

Status epilepticus drugs pocket card from CHEST. #FOAMed #FOAMcc #ICU

1/ The @UFNeuroICU Research Team proudly presents their latest manuscript! Efficacy of COXIBs for headache after ABI— A systematic review: bit.ly/3XlLchX A 🧵with key points from our paper: #NeuroTwitter

Yi Ong et al: Electroconvulsive Therapy in Refractory and Super-Refractory Status Epilepticus in Adults: A Scoping Review Link: link.springer.com/article/10.100… Neurocritical Care Society #neurocritcare

This will require in depth reading and discussion later… One of the few studies on transfusion thresholds where liberal seems better. All randomized patients were anemic.

Kartal et al: How to Define and Meet Blood Pressure Targets After Traumatic Brain Injury: A Narrative Review Link: ow.ly/CTrv50TtSUe Neurocritical Care Society #neurocritcare

Looking forward to this discussion on Neurosurgical Robotics! Jefferson Neurosurgery Jefferson Health EIC of the JNSPG Journal of Neurosurgery

#tjuhneurocritcare, #nccsymposium

Dr. Ume presenting on Status Epilepticus and NORSE. #NCCSymposium, #JeffersonNeurocritCare

Thank you to Dr. Emily Gilmore for giving a fantastic talk on Neuromonitoring at the NCC Symposium. Jefferson Neurology Jefferson Neurosurgery

Thoughtful presentation by Dr. Monisha Kumar on the impact of health care disparities. Jefferson Neurology Jefferson Neurosurgery

Looking for a great neurocritical care fellowship?